At CFO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Australia based CFO’ operating in the Biotechnology space. If you think a CFO’ is missing from this list, feel free to contact our editor on [email protected].
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
CFO of Mayne Pharma
Peter Paltoglou has over 15 years of experience in executing public and private mergers and acquisitions, capital management and providing strategic advice across a range of contexts and market sectors. He was previously Managing Director of Investment Banking at Credit Suisse Emerging Companies in Australia. Prior to Credit Suisse,Peter Paltoglou was a Director of Hindal Group, a boutique M&A advisory business.
Follow Peter Paltoglou:
About Mayne Pharma: Mayne Pharma Group, a specialist pharmaceutical company, optimizes and delivers oral drugs.
Chief Financial Officer of Refeyn
Andrew Justo is the Chief Financial Officer at Refeyn.
Follow Andrew Justo:
About Allume Energy, Refeyn: Refeyn is specialising in label-free single molecule imaging and mass measurement.
CFO of QRxPharma
Mr Campbell joined QRxPharma in 2007, prior to which he served as Chief Financial Officer of CAP-XX Limited, an Australian technology company, for six years. In his role as CFO of CAP-XX, he was closely involved with the listing of the company on the London Stock Exchange Alternative Investment Market in 2006. Mr Campbell has also previously held senior finance roles in the telecommunications, manufacturing, construction and services sectors. Mr Campbell was Chief Financial Officer and an Executive Director of Lucent Technologies Australia Limited (2000 to 2001), and Finance Manager for the Australia/Asia Pacific Explosives Group of Orica Limited (ASX: ORI) from 1994 to 2000. Mr Campbell holds a Bachelor of Commerce and is an Associate of the Institute of Chartered Accountants in Australia.
Follow Chris Campbell:
About QRxPharma: QRxPharma is a pharmaceutical company that develops and commercializes pain management and abuse prevention products.
CFO and Company Secretary of Neuren Pharmaceuticals
Jonathan Pilcher is a Chartered Accountant and holds a degree in biotechnology from Reading University in the UK. He was previously the CFO and Company Secretary of Acrux Limited for eleven years and brings a wealth of experience in a wide range of matters relating to the funding, growth and compliance of a registered Pooled Development Fund. Jon is currently the CFO and Company Secretary of Neuren Pharmaceuticals Limited
Follow Jonathan Pilcher:
About Neuren Pharmaceuticals: Neuren Pharmaceuticals is a biopharmaceutical company developing drugs for the treatment of brain injuries and neurodegeneration.
Sofie De Wolf
CFO of OncoRes Medical
Sofie is a qualified accountant with international experience in investment fund accounting and fund reporting. Originally from Belgium, Sofie started her financial career in Dublin (Ireland) where she worked for Citco Fund Services and AIB/BNY Fund Management as a fund accountant and fund reporting supervisor, responsible for the accounting and reporting function of various types of funds. Sofie is the Financial Controller at Stone Ridge Ventures, responsible for the financial operations and reporting of the management company, the SRV Trusts and various portfolio companies. Sofie also assumes the role of Company Secretary for these entities. Sofie is a member of the Association of Chartered Certified Accountants (ACCA). She received the silver medal for achieving the 2nd highest mark worldwide in her final accounting exams. In 2009 she was awarded the WA Dux prize for Applied Corporate Law by Chartered Secretaries Australia (CSA).
Follow Sofie De Wolf:
About OncoRes Medical: OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons.
CFO of Universal Biosensors
Follow Salesh Balak:
About Universal Biosensors: Universal Biosensors is a medical diagnostics firm that researches, develops, and manufactures diagnostic test systems for POC and home use.